Search company, investor...


Founded Year



Seed VC | Alive

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+30 points in the past 30 days

About Oncoshot

Oncoshot provides clinical trials and treatment options for cancer patients. The company allows patients to share their data with trial institutes and sponsors and receive an immediate response, shortening the clinical trial search from weeks to minutes. Its platform is used by industry partners, hospitals, patients, and caregivers. Oncoshot was founded in 2018 and is based in Singapore.

Headquarters Location

67 Ayer Rajah Crescent 02-10/17



Missing: Oncoshot's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Oncoshot's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Oncoshot

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Oncoshot is included in 4 Expert Collections, including Clinical Trials Tech.


Clinical Trials Tech

366 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.



2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Digital Health

13,069 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Biopharma Tech

326 items

Latest Oncoshot News

Oncoshot and Novotech Partner to Offer Cancer Data Insights

Nov 11, 2022

Oncoshot and Novotech Partner to Offer Cancer Data Insights Share: SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Oncoshot and internationally recognised contract research organisation (CRO) Novotech have begun a partnership to enhance clinical trial management success. This collaborative partnership will grant exchange and insights into real-time population data between both organisations and their affiliated leading cancer research centres. Novotech, the leading Asia-Pacific biotech specialist CRO, presently has offices in 11 geographies across the region, and site partnerships with over 45 key medical institutions. CROs provide clinical trial services for pharmaceutical, biotechnology, and medical device institutes. In the last decade, the industry has shifted the operations of clinical research from a vertical and fixed reporting model, with many in-house professionals dedicated to clinical studies, to a matrix model involving both internal and external resources, and then gradually moving a large proportion of the work to CROs. As the industrial approach to clinical research spread from the USA and Europe to most parts of the globe, the number of clinical studies increased continuously, and CROs became bigger. The pressure for tighter timelines increased; even Big Pharma started to have difficulties coping with the increased workload, leading to an increase in outsourcing. As a provider of clinical development services across all clinical trial phases and therapeutic areas, Novotech will leverage the Oncoshot platform to understand matching populations across key clinical trial markets in the APAC region. Oncoshot provides a safe and secure insights-sharing framework where Novotech can conduct feasibilities with data-ready trial sites aggregated on the platform to enable greater ease of engagement and efficiency in starting and conducting clinical trials. Novotech will be able to access national-level genomic screening partners such as Omico, as well as engage with leading cancer hospitals for feasibilities and continuously refreshed data that will support screening and enrolment throughout the duration of clinical trials. "Novotech is pleased to partner with Oncoshot to enhance client data in cancer patient populations. The partnership gives Novotech and its biotech clients access to the Oncoshot platform that provides real-time information from aggregated data-ready trial sites. This supports clinical study feasibility processes," said Daniela Caiazza, senior director of clinical services and innovation at Novotech. The crucial criteria for selecting a CRO include its service catalogue, experience, knowledge of the disease, access to patients, geographical coverage, quality management, responsiveness, staff continuity and proficiency, technology, financial stability, and pricing. By integrating the Oncoshot platform into its workflow in some of the key regions across the Asia Pacific, Novotech will be better equipped to identify sites, assess their feasibility, and identify patient geographies. About Oncoshot Oncoshot was founded in 2018 by Dr Huren Sivaraj, a medical oncologist, and Ruslan Enikeev, a data science engineer. Oncoshot's mission is to help oncologists identify cancer clinical trials more efficiently and effectively for patients and their caregivers by supporting hospitals and research partners. Its current focus is to leverage technology to address the inefficiencies of cancer clinical trials. Oncoshot has expanded to Australia and India since its inception in Singapore, an act that highlights its applicability and success. For more information, visit . About Novotech Novotech is the leading Asia-Pacific biotech specialist CRO. Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases. It has been instrumental in the success of approximately 4,000 clinical trials across a broad range of therapeutic areas. Novotech is well-positioned to serve biopharma clients conducting clinical trials in Asia-Pacific and the US. Source: Oncoshot

Oncoshot Frequently Asked Questions (FAQ)

  • When was Oncoshot founded?

    Oncoshot was founded in 2018.

  • What is Oncoshot's latest funding round?

    Oncoshot's latest funding round is Seed VC.

  • Who are the investors of Oncoshot?

    Investors of Oncoshot include MassMutual Ventures.

  • Who are Oncoshot's competitors?

    Competitors of Oncoshot include TriNetX and 2 more.

Compare Oncoshot to Competitors

Aetion Logo

Aetion delivers real-world evidence for life sciences companies, payers, at-risk providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce rapid and scientifically validated answers on treatments, costs, and outcomes. Aetion informs health care's most critical decisions - what works best, for whom, and when - to guide treatment development, commercialization, and payment values into health care's modern era.

Evidation Logo

Evidation measures health in everyday life and enables anyone to participate in research and health programs. Evidation is a two-sided platform that connects individuals and enterprises. On the consumer side, the company assists individuals to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, med-tech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.


Verantos provides high-validity real-world evidence for life sciences. By incorporating robust clinical narrative data, AI technology, and measured validity, Verantos generates research-grade evidence at scale across all therapeutic areas. The Verantos Evidence Platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for market access, HEOR, medical affairs, and regulatory use. The company was founded in 2015 and is based in Menlo Park, California.

Mango Sciences

Mango Sciences is an emerging market data science company that connects underrepresented patients to precision medicine. The company's platform utilizes AI analytics to transform deep clinical data into key insights. It is based in Boston, Massachusetts.


Vitalief is a clinical trials solutions company that supports clients in planning and executing clinical trials. It recruits top talent from across the clinical research industry to support its clients in planning and execution of successful clinical trials with the goal of having a positive impact on people’s lives. The company was founded in 2021 and is based in New Brunswick, New Jersey.

ZS Associates

ZS Associates helps companies to improve overall performance and grow revenue and market share through end-to-end sales and marketing solutions-from customer insights and strategy to analytics, operations, and technology. It uses analytics, data, science, and products to help clients make decisions, deliver solutions and improve outcomes. The firm was founded in 1983 and is based in Evanston, Illinois.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.